Becker's Healthcare November 17, 2022
Paige Twenter

As the team of 33 at Mark Cuban Cost Plus Drug Co. works to serve its 1.3 million customers, Mr. Cuban told Time his planned next steps for the company that looks to disrupt the $1.4 trillion pharmaceutical industry.

Since its launch in January, Cost Plus Drug Co. has gone from selling 100 drugs to about 1,000 — some of which cost more than 90 percent less than the market price — but it has yet to break into larger pieces of the market, such as brand-name drugs. In October, the company partnered with its first payer, Capital Blue Cross, and Mr. Cuban said he expects to take more insurance plans in 2023.


Today's Sponsors


Today's Sponsor


Topics: Pharma, Pharma / Biotech
ASH: Pfizer, swimming in crowded waters, eyes wide impact for sickle cell, hemophilia assets
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
Merck suffers bad week as 3 Keytruda combination trials fail
Walgreens expands testing, treatment options for COVID-19, flu
SABCS: As Lilly showdown nears, Novartis gives another look at Kisqali data in early breast cancer

Share This Article